Nonsteroidal Anti-Inflammatory Drug Use and Breast Cancer Risk by Stage and Hormone Receptor Status
Sarah F. Marshall et al, 2005, JNCI: Journal of the National Cancer Institute CrossRef
Aspirin and Other Nonsteroidal Anti-inflammatory Drugs and Breast Cancer Incidence in a Large U.S. Cohort
Eric J. Jacobs et al, 2005, Cancer Epidemiology, Biomarkers & Prevention CrossRef
Cyclooxygenase-2 and the inflammogenesis of breast cancer
Randall E Harris, 2014, World Journal of Clinical Oncology CrossRef
Nonsteroidal Anti-inflammatory Drug Use and Serum Total Estradiol in Postmenopausal Women
Alana G. Hudson et al, 2008, Cancer Epidemiology, Biomarkers & Prevention CrossRef
Nonsteroidal Anti-inflammatory Drugs and Change in Mammographic Density: A Cohort Study Using Pharmacy Records on Over 29,000 Postmenopausal Women
Mary Beth Terry et al, 2008, Cancer Epidemiology, Biomarkers & Prevention CrossRef
Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP1 antagonist, on breast cancer development
Toshihiko Kawamori et al, 2001, Carcinogenesis CrossRef
Use of Nonsteroidal Antiinflammatory Drugs and Non-Hodgkin Lymphoma: A Population-based Case-Control Study
E. Dawn Flick et al, 2006, American Journal of Epidemiology CrossRef
3-Phosphoinositide-Dependent Protein Kinase-1/Akt Signaling Represents a Major Cyclooxygenase-2-Independent Target for Celecoxib in Prostate Cancer Cells
Samuel K. Kulp et al, 2004, Cancer Research CrossRef
Use of Common Medications and Breast Cancer Risk
Kirsten B. Moysich et al, 2008, Cancer Epidemiology, Biomarkers & Prevention CrossRef
Use of Nonsteroidal Antiinflammatory Drugs and Risk of Breast Cancer: The Case-Control Surveillance Study Revisited
Yuqing Zhang et al, 2005, American Journal of Epidemiology CrossRef
Association between Nonsteroidal Anti-inflammatory Drug Use and the Incidence of Lung Cancer in the Iowa Women's Health Study
Jennifer H. Hayes et al, 2006, Cancer Epidemiology, Biomarkers & Prevention CrossRef